Cargando…

Variability in the Calculation of Time in Therapeutic Range for the Quality Control Measurement of Warfarin

Time in therapeutic range (TTR), a well-recognized performance metric of oral anticoagulation, measures the time when patients’ international normalized ratios (INRs) are within the desired range. The TTR value can vary significantly depending on the type of method used and can be a skewed indicator...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siddiqui, Safia, DeRemer, Christina E., Waller, Jennifer L., Gujral, Jaspal S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MediaSphere Medical 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252856/ https://www.ncbi.nlm.nih.gov/pubmed/32494479 http://dx.doi.org/10.19102/icrm.2018.091203

Ejemplares similares

Management of Warfarin Anticoagulated Patients Choosing Hyperbaric Oxygen Treatments
por: DeRemer, Christina E., et al.
Publicado: (2019)

The awareness, efficacy, safety, and time in therapeutic range of warfarin in the Turkish population: WARFARIN-TR
por: Çelik, Ahmet, et al.
Publicado: (2016)

Comparative effectiveness and safety of direct oral anticoagulants versus warfarin among patients with recurrent venous thromboembolism
por: Kang, Hye‐Rim, et al.
Publicado: (2023)

Trajectories of adherence to extended treatment with warfarin and risks of recurrent venous thromboembolism and major bleeding
por: Kang, Hye-Rim, et al.
Publicado: (2023)

Pharmaceutical Care Increases Time in Therapeutic Range of Patients With Poor Quality of Anticoagulation With Warfarin
por: Marcatto, Leiliane Rodrigues, et al.
Publicado: (2018)

Quality Improvement Program Improves Time in Therapeutic Range for Hemodialysis Recipients Taking Warfarin
por: Blum, Daniel, et al.
Publicado: (2019)

Alternative Calculations of Individual Patient Time in Therapeutic Range While Taking Warfarin: Results From the ROCKET AF Trial
por: Singer, Daniel E., et al.
Publicado: (2015)

Identification of environmental and genetic factors that influence warfarin time in therapeutic range
por: Botton, Mariana R., et al.
Publicado: (2020)

Patients’ time in therapeutic range on warfarin among atrial fibrillation patients in Warfarin Medication Therapy Adherence Clinic
por: Lee, Siew Ling, et al.
Publicado: (2021)

Clinically Relevant Drug Interactions in the Cancer Setting
por: DeRemer, David
Publicado: (2022)

Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation
por: Marcatto, Leiliane Rodrigues, et al.
Publicado: (2016)

The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study
por: Kılıç, Salih, et al.
Publicado: (2017)

Limited English Proficient Patients and Time Spent in Therapeutic Range in a Warfarin Anticoagulation Clinic
por: Rodriguez, Fátima, et al.
Publicado: (2013)

Clinical Prediction Model for Time in Therapeutic Range While on Warfarin in Newly Diagnosed Atrial Fibrillation
por: Williams, Brent A., et al.
Publicado: (2017)

Long-Term Statin Administration Does Not Affect Warfarin Time in Therapeutic Range in Australia or Singapore
por: Bernaitis, Nijole, et al.
Publicado: (2018)

Evaluation of Bleeding Rate and Time in Therapeutic Range in Patients Using Warfarin Before and During the COVID-19 Pandemic—Warfarin Treatment in COVID-19
por: Emren, Zeynep Yapan, et al.
Publicado: (2021)

Pharmacogenetics of warfarin in a paediatric population: Time in therapeutic range, initial and stable dosing, and adverse effects
por: Hawcutt, Daniel B, et al.
Publicado: (2014)

Time in Therapeutic Range Using a Nomogram for Dose Adjustment of Warfarin in Patients on Hemodialysis With Atrial Fibrillation
por: Defoe, Kimberly, et al.
Publicado: (2021)

Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction
por: Szummer, Karolina, et al.
Publicado: (2017)

Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation
por: Jansson, M., et al.
Publicado: (2023)

Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia
por: DeRemer, David L, et al.
Publicado: (2011)

Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study
por: Ng, Diana-Leh-Ching, et al.
Publicado: (2020)

Relationship Between Time in Therapeutic Range and Comparative Treatment Effect of Rivaroxaban and Warfarin: Results From the ROCKET AF Trial
por: Piccini, Jonathan P., et al.
Publicado: (2014)

Impact of an ambulatory care pharmacist on provider relative value units in a rural clinic
por: DeRemer, Christina E., et al.
Publicado: (2021)

Physician–Pharmacist Collaborative Clinic Model to Improve Anticoagulation Quality in Atrial Fibrillation Patients Receiving Warfarin: An Analysis of Time in Therapeutic Range and a Nomogram Development
por: Wang, Na, et al.
Publicado: (2021)

Impact of Global Geographic Region on Time in Therapeutic Range on Warfarin Anticoagulant Therapy: Data From the ROCKET AF Clinical Trial
por: Singer, Daniel E., et al.
Publicado: (2013)

Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH)
por: Wen, Xuerong, et al.
Publicado: (2021)

Factors Influencing Prescribers' Decision for Extending Venous Thromboembolism Prophylaxis in the Medical Patient Population following Hospitalization
por: Ebied, Alex M., et al.
Publicado: (2020)

Lower dose direct oral anticoagulation or warfarin in atrial fibrillation. Which one is the best when time on therapeutic range information is available?
por: Luojus, A, et al.
Publicado: (2023)

Is the time in therapeutic range on coumarins predicted by previous time in therapeutic range?
por: van Miert, Jasper H. A., et al.
Publicado: (2020)

Warfarin Toxicity and Individual Variability—Clinical Case
por: Piatkov, Irina, et al.
Publicado: (2010)

Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range – study protocol for a randomized controlled trial
por: Marcatto, Leiliane Rodrigues, et al.
Publicado: (2016)

The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: A systematic review and meta-regression analysis
por: Vestergaard, Anne Sig, et al.
Publicado: (2017)

Comparison of Patient Outcomes Before and After Switching From Warfarin to a Direct Oral Anticoagulant Based on Time in Therapeutic Range Guideline Recommendations
por: Haymart, Brian, et al.
Publicado: (2022)

Warfarin Time in Therapeutic INR Range and Direct Oral Anticoagulant Adherence for Venous Thromboembolism Across the Spectrum of Weight and Body Mass Index: Findings from Veterans Health Administration
por: Din, Natasha, et al.
Publicado: (2023)

Time in therapeutic range and stability over time for warfarin users in clinical practice: a retrospective cohort study using linked routinely collected health data in Alberta, Canada
por: McAlister, Finlay A, et al.
Publicado: (2018)

Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell Mobilization
por: Awan, Farrukh T., et al.
Publicado: (2012)

Dying to be Ill: Munchausen meets warfarin overdose
por: Akella, Padmastuti, et al.
Publicado: (2019)

Comparative effectiveness and safety of extended anticoagulant therapy among Medicare beneficiaries with venous thromboembolism
por: Park, Haesuk, et al.
Publicado: (2022)

Warfarin Quality Metrics for Hospitalized Older Adults
por: Cohen, Jessica, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lan6s8fbaee30cfpucahksk5ou